BIOMAT Database Logo BIOMAT Database Logo

Safety of baricitinib in patients with alopecia areata. 2023

Robert Bissonnette
Innovaderm Research Inc., Montreal, Quebec, Canada.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000506 Alopecia Areata Loss of scalp and body hair involving microscopically inflammatory patchy areas. Alopecia Circumscripta
D001384 Azetidines
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide

Related Publications

Robert Bissonnette
Efficacy and safety of baricitinib in patients with refractory alopecia areata.
December 2022, Dermatologic therapy,
Robert Bissonnette
Safety of baricitinib in adults with severe alopecia areata.
February 2023, The British journal of dermatology,
Robert Bissonnette
Baricitinib in Alopecia Areata.
May 2022, The New England journal of medicine,
Robert Bissonnette
Efficacy and safety of baricitinib in patients with alopecia areata: evidence to date.
January 2023, Drugs in context,
Robert Bissonnette
Baricitinib for alopecia areata.
May 2023, JPMA. The Journal of the Pakistan Medical Association,
Robert Bissonnette
Baricitinib therapy for paediatric patients with severe alopecia areata.
May 2024, Journal of the European Academy of Dermatology and Venereology : JEADV,
Robert Bissonnette
Treatment of severe alopecia areata with baricitinib.
October 2019, JAAD case reports,
Robert Bissonnette
Baricitinib (Olumiant) for severe alopecia areata.
September 2022, The Medical letter on drugs and therapeutics,
Robert Bissonnette
Alopecia areata treatment with baricitinib: different relapse phenotypes.
December 2024, The Journal of dermatological treatment,
Robert Bissonnette
Baricitinib: A Review in Severe Alopecia Areata.
July 2023, American journal of clinical dermatology,
Copied contents to your clipboard!